Cord Blood Transplantation in 2 Infants Presenting Monosomy 7 Clonal Hematopoiesis: SAMD9 / SAMD9L Germline Mutation. 2023

Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
Department of Pediatrics and Child Health, Nihon University Itabashi Hospital.

Recently, germline mutations in SAMD9 and SAMD9L were increasingly found in children with monosomy 7. We report the outcomes in 2 infants with the SAMD9/SAMD9L variant, who presented with anemia and thrombocytopenia (patient 1), and neutropenia and nonsymptomatic white-matter-encephalopathy (patient 2). Both patients received cord blood transplantation and experienced critical post-cord blood transplantation adverse events; patients 1 and 2 developed fulminant engraftment syndrome and life-threatening graft-versus-host disease, respectively. Of note, selective loss of chromosome 7 in bone marrow-derived CD34 + cells was inferred.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082182 Clonal Hematopoiesis Expansion of blood cells arising from mutant HEMATOPOIETIC STEM CELLS often related to aging. Mutations on epigenetic regulator genes are common in clonal hematopoiesis and may be a risk factor for HEMATOLOGIC NEOPLASMS and other cardiovascular diseases. When variant allele fraction is at least 2% and is present in the absence of severe cytopenias it is referred to as clonal hematopoiesis of indeterminate potential (CHIP). ARCH Age-related Clonal Hematopoiesis,Age-related Clonal Hematopoiesis,CCUS Clonal Cytopenia of Undetermined Significance,CHIP Clonal Hematopoiesis of Indeterminate Potential,Clonal Cytopenia of Undetermined Significance,Clonal Hematopoiesis of Indeterminate Potential,ICUS Idiopathic Cytopenias of Undetermined Significance,Idiopathic Cytopenias of Undetermined Significance,ARCH Age related Clonal Hematopoiesis,Age related Clonal Hematopoiesis,Clonal Hematopoiesis, Age-related,Hematopoiesis, Age-related Clonal,Hematopoiesis, Clonal
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D047908 Intracellular Signaling Peptides and Proteins Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors. Intracellular Signaling Peptides,Intracellular Signaling Proteins,Peptides, Intracellular Signaling,Proteins, Intracellular Signaling,Signaling Peptides, Intracellular,Signaling Proteins, Intracellular
D018095 Germ-Line Mutation Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not. Mutation, Germ-Line,Germline Mutation,Germ Line Mutation,Germ-Line Mutations,Germline Mutations,Mutation, Germ Line,Mutation, Germline,Mutations, Germ-Line,Mutations, Germline
D025521 Tumor Suppressor Proteins Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development. Growth Suppressor Proteins,Metastasis Suppressor Protein,Metastasis Suppressor Proteins,Tumor Suppressor Protein,Protein, Metastasis Suppressor,Protein, Tumor Suppressor,Proteins, Growth Suppressor,Proteins, Metastasis Suppressor,Proteins, Tumor Suppressor,Suppressor Protein, Metastasis,Suppressor Protein, Tumor

Related Publications

Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
August 2017, Leukemia,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
April 2024, Experimental hematology,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
October 2021, Nature medicine,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
November 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
December 2021, Nature medicine,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
November 2018, Blood,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
December 2020, British journal of haematology,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
September 2023, Leukemia research,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
February 2024, Seminars in hematology,
Maiko Hirai, and Hiroshi Yagasaki, and Koji Kanezawa, and Masaru Ueno, and Katsuyoshi Shimozawa, and Kohsuke Imai, and Tomohiro Morio, and Motohiro Kato, and Yoshihiro Gocho, and Satoshi Narumi, and Yasuhiro Ebihara, and Ichiro Morioka
July 2018, JCI insight,
Copied contents to your clipboard!